KEYWORD SEARCH

NEWS

REaSoN 2017 Puts On a Great Show

.

Inspiration Healthcare attended the 23rd annual REaSoN Neonatal meeting on 2nd-4th July at the University of Warwick.

As platinum sponsors for the fourth consecutive year, Inspiration Healthcare showcased its innovative Neonatal product range to more than 300 experts from the field of neonatology and paediatrics. 

REaSoN’s relevant, exciting and engaging 2 day programme provided Inspiration Healthcare with an excellent opportunity to gain a better understanding of some of the current clinical topics being addressed around the world. 

The 2017 scientific programme considered many hot topics in neonatal care including a great talk from Dr Boubou Hallberg, Head of the Karolinska Institute in Stockholm, on the IGF1/IGF1BP hormone supplementation in preterm infants. Low levels of the hormone are correlated with complications in prematurity which include lung immaturity, retinal immaturity leading to Retinopathy of Prematurity (ROP) and brain development abnormalities.  In his talk Dr Boubou Hallberg explained how levels of the hormone drop when the umbilical cord is immediately cut at birth.  Further work is also underway to look at the role the hormone plays in reducing Bronchopulmonary Dysplasia (BPD) and Intraventricular Haemorrhage (IVH).    

When asked about the impact this research could make Nicky Reeves-Brown, Product Manager at Inspiration Healthcare, commented: “This is exciting research presented by Dr Boubou Hallberg, and important to learn about the part the IGF1/IGF1BP hormone may play in supporting the transition of babies and improving clinical outcomes”.   

The programme also featured a talk from Dr Charles Christoph Roehr, who presented data on the LISA/MIST surfactant delivery technique.  Key messages from the session included that the technique is feasible, it reduces the risks of CPAP failure and the need for mechanical ventilation, and reduces BPD at 36 weeks corrected. 

Nicky Reeves-Brown added: “It will be interesting to see how these techniques are implemented into standard practice.   If surfactant needs to be administered in the delivery room a less invasive strategy would be preferred for our infants.  The LISA/MIST technique would be a welcome addition to our stabilisation strategy in the delivery room alongside the Inspire rPAP™. The advantage of using nasal prongs for stabilisation is that the LISA/MIST technique could potentially be introduced earlier in a hospital’s transitional care strategy”. 

Inspiration Healthcare was delighted to introduce Prof. Eugene Dempsey, of the Cork University Maternity Hospital and INFANT Centre as guest speaker for their sponsored symposium on the second day of the conference. Entitled ‘Clamping the Umbilical Cord in Preterm Infants (CUPiD): Results of a Feasibility Trial’, Prof. Dempsey’s symposium concluded that Delayed Cord Clamping with bedside resuscitation using the LifeStart™ resuscitation unit is feasible without maternal or neonatal adverse effects, and that a future appropriately powered trial is needed. 

Charndeep Khattar, Marketing Director of Inspiration Healthcare, concluded: “The scientific programme for REaSoN 2017 has been exceptionally strong and we look forward to seeing how these topics develop over the coming months. It is vital to stay abreast of current worldwide developments to determine how our products can help translate this research into clinical practice, and REaSoN provides a perfect platform to do this”.      

Photo: Inspiration Healthcare staff joined by delegates during a break-out session
FOR MORE INFORMATION
CALL US NOW ON +44(0)1455 840 555
OR EMAIL INFO@INSPIRATION-HEALTHCARE.COM

WATCH THE

LATEST

VIDEO

.

Live Chat Software